pSivida Corp. Stock Nasdaq

Stocks

09/08/16	PSivida : Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle	PU
14/07/16	PSivida : Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve	PU
02/05/16	PSivida : Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe	PU
28/09/15	PSivida : Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs	BU
14/09/15	PSivida : CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015	BU

1 day

-0.87%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PSIVIDA CORP.	-0.87%	-2.40%	-	-	0
ARGENX SE	-2.86%	-0.63%	+51.45%	+109.01%	56.42B
WUXI APPTEC CO., LTD.	-0.34%	+2.91%	+45.55%	+46.87%	44.54B
BIONTECH SE	+0.29%	+3.09%	-14.80%	-18.16%	22.9B
INSMED INCORPORATED	-0.40%	+3.44%	-1.29%	+405.24%	21.21B
WUXI BIOLOGICS (CAYMAN) INC.	-0.51%	-5.56%	+10.43%	-29.97%	16.4B
GENMAB A/S	-1.54%	+0.66%	+7.63%	-40.19%	15.4B
EXELIXIS, INC.	-0.24%	+0.57%	+27.43%	+182.22%	13.35B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+0.96%	+6.56%	+20.81%	-	12.36B
PHARMAESSENTIA CORPORATION	+0.32%	+1.60%	+96.37%	+207.56%	11.15B
Average	-0.52%	+1.66%	+27.07%	+107.82%	23.75B
Weighted average by Cap.	-0.93%	+2.54%	+30.66%	+99.59%